Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | HIV: Markets for Diagnostics and Therapeutics

HIV: Markets for Diagnostics and Therapeutics

The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics and therapeutics, companies must think on a global basis. In addition to the basic pathology and complications of HIV/AIDS, there are primarily three focal points for the development of strategy in this area: potential market, epidemiology (HIV/AIDS patient trends) and technology.

In his report HIV Markets for Diagnostics and Therapeutics, anlayst Kenneth Krul, PhD examines these focal points, with an eye to creating a comprehensive look at the market and opportunity for both testing and treatments of HIV. Dr. Krul takes a look at the potential theoretical markets and what will be realistic in the current world healthcare system.

The report contains extensive epidemological statistics for HIV in the following WHO health regiions:

* Sub-Saharan Africa

* Middle East and North Africa

* South and South-East Asia

* East Asia

* Latin America

* Caribbean

* Eastern Europe and Central Asia

* Western and Central Europe

* North America

* Oceania

In addition the report contains:

* Current Market Sizes for HIV Treatments and Diagnostics in each WHO Health Region (treatment and diagnostic markets)

* Profiles of Companies in this Market

* Eleven Important Conclusions

* Review of Current Treatment Products and Diagnostic Tools.

As with all Kalorama Information reports, this product is the result of primary and secondary research. Interviews with experts, as well as research into company reports, medical literature and government data is included.

Oct 1, 2008

250 Pages - Pub ID: KLI1646600
Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions